EASTERLY INVESTMENT PARTNERS LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
EASTERLY INVESTMENT PARTNERS LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,232,133
-4.2%
205,643
+119.0%
0.47%
+19.2%
Q2 2023$4,416,165
+30.5%
93,921
+16.5%
0.39%
+31.2%
Q1 2023$3,383,864
+12.8%
80,645
+2.5%
0.30%
+15.1%
Q4 2022$2,999,520
+20.3%
78,645
+23.5%
0.26%
+8.4%
Q3 2022$2,493,000
+16.7%
63,665
-3.8%
0.24%
+25.8%
Q2 2022$2,137,000
+92.2%
66,165
+96.9%
0.19%
+126.2%
Q1 2022$1,112,00033,6100.08%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders